Cases from the Clinic: Focus on Endometrial Cancer is organized by Healio, Integrity Continuing Education Inc.
Release Date: July 12, 2023
Expiration Date: July 12, 2024
Activity Description:
The treatment options for endometrial cancer (EC) have expanded in the last five years to include immunotherapy (IO) alone or combined with chemotherapy or tyrosine kinase inhibitors (TKIs), and DNA mismatch repair deficiency (dMMR) and microsatellite instability (MSI) have emerged as an actionable biomarker in advanced EC.?These IO regimens have well-documented safety and efficacy. Obtaining optimal outcomes, therefore, necessitates a precision-medicine approach that tailors therapy based on patient and disease characteristics and incorporates the patient’s circumstances and personal wishes into the treatment planning process.
Learning Objectives:
Upon completion of this educational activity, participants should be able to:
• Evaluate treatment options using patient and disease characteristics, plus integrate factors that contribute to improved patient quality of life
• Monitor and mitigate treatment-related adverse events